Globus Medical, Inc. Class A Common Stock (GMED)
EBITDA
$259.32M
Quarterly · Period ending: · USD
GMED EBITDA
Latest reported$259.32Mperiod ending
Latest reported$259.32Mperiod ending
GMED Quarterly EBITDA ($27.15M → $259.32M)
Quarterly EBITDA
High-resolution chart · PNG
GMED ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 259,316,000 | |
| 226,930,000 | |
| 244,392,000 | |
| 215,120,000 | |
| 193,443,000 | |
| 164,135,000 | |
| 145,283,000 | |
| 115,943,000 | |
| 126,378,000 | |
| 84,817,000 | |
| 97,116,000 | |
| 86,341,000 | |
| 87,254,000 | |
| 75,872,000 | |
| 78,729,000 | |
| 76,628,000 | |
| 83,599,000 | |
| 65,547,000 | |
| 42,916,000 | |
| 71,048,000 | |
| 78,876,000 | |
| 71,885,000 | |
| 77,414,000 | |
| 67,577,000 | |
| -10,209,000 | |
| 43,564,000 | |
| 61,706,000 | |
| 57,820,000 | |
| 55,834,000 | |
| 49,912,000 | |
| 55,399,000 | |
| 49,030,000 | |
| 57,090,000 | |
| 55,262,000 | |
| 57,032,000 | |
| 46,457,000 | |
| 48,662,000 | |
| 53,236,000 | |
| 52,548,000 | |
| 45,898,000 | |
| 44,756,000 | |
| 49,791,000 | |
| 62,242,000 | |
| 46,676,000 | |
| 43,098,000 | |
| 43,569,000 | |
| 40,917,000 | |
| 39,991,000 | |
| 37,070,000 | |
| 37,583,000 | |
| 41,570,000 | |
| 34,461,000 | |
| 34,203,000 | |
| 33,891,000 | |
| 32,932,000 | |
| 31,702,000 | |
| 33,934,000 | |
| 32,746,000 | |
| 29,929,000 | |
| 30,855,000 | |
| 27,864,000 | |
| 27,147,000 |